(OTC:SPRV) is involved in the acquisition and development of real estate within the medical office building sector. On the 12th February 2021 the company has hired a new President and CEO to take the company to the next level: John D. Murphy. The CEO John D. Murphy stated: “with the Company’s acquisition of a free standing medical office building, the Company is well positioned to becoming a leader in the fast growing medical office building sector.” Let me introduce you to John D. Murphy:
John D. Murphy:
– 30 years of experience in design, development, construction, leasing, and management of acquisitions of Medical building offices (MOB)
– New York
– South Carolina – Tennesee
This sums up a total of $150,000,000
First deal for Supurva: Medical Office Building in Jupiter, Florida
– Two story building
– 31,000 sq feet
– 12 years remaining triple-net-term leases with rent escalation clauses. – Well-established multi-specialty medical practice
March 24, 2021: Four Letter of Intents signed to acquire four more Medical Office Buildings
– Two buildings in Greenville, Columbia and South Carolina
– Two buildings in South West Florida
– Ranging between 10,000 – 40,000 sq feet
– Fully leased to financially strong health systems.
– Tenants are subject to long-term, triple-net-term leases with rent escalation clauses.
Upcoming shareholders meeting has been planned and John D. Murphy made some comments about it: John Murphy, the Company’s CEO, summarized as follows,
We have already filed a confidential Registration Statement with the SEC, and once our Registration Statement is deemed effective, management will immediately schedule a Shareholder Meeting to discuss Supurva’s business plans and strategy over the next 12 months.
This will include an eventual authorized capital share reduction in line with ongoing restructuring goals. I would also like to inform our current shareholders and the investment community that our tradable float is 116,561,268 shares, and we will be updating that number with OTC Markets.
“The Company remains poised to expand its portfolio of medical office buildings(“MOBs”) as recently outlined in our Press Release, dated March 21, 2021, while simultaneously building measurable intrinsic shareholder value in the MOB (medical building office) sector.”
“We anticipate providing even more details of our progress over the near-term in as full and transparent of a manner as possible while adhering to good corporate governance guidelines. I am personally thrilled to finally have Supurva positioned for meaningful growth over the next 12 months and am looking forward to keeping our shareholders and the investment community at large aware of our material progress at every juncture.”John D. Murphy – CEO
Supurva Health Group, Inc (SPRV) will be growing and targeting opportunities in this sector together with veteran John D. Murphy along their side. This sector is benefiting from the low-interest rates and favorable tax conditions in some areas.
The four Letter of Intents has shown that John D. Murphy has been very active in the company’s operations and the companys’ short and long term growth. Associates close to Mr. Murphy, confirmed that he brings great enthusiasm and an astute business skillset, honed by his decades of experience in the real estate and medical fields.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.